Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Base up .05 per share

RE: Base up .05 per share

posted on Jun 26, 2006 06:03AM
If we can stabilize .05 per share higher after each deal. We will be at $15 per share after we license all 300 companies. I can live with that! Just having some fun. obviously the buying and selling frenzie seems to have disipated for now.

The news today was great, with 300 companies now put on notice and future acquisition possible.

All in good time.

All the best,

Steve

Share
New Message
Please login to post a reply